» Articles » PMID: 15207630

Characterization of the Hepatitis C Virus RNA Replication Complex Associated with Lipid Rafts

Overview
Journal Virology
Specialty Microbiology
Date 2004 Jun 23
PMID 15207630
Citations 131
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism and machinery of hepatitis C virus (HCV) RNA replication are still poorly characterized. Our previous study has shown that HCV RNA synthesis occurs on a lipid raft membrane structure [J. Virol. 77 (2003) 77 4160]. In this study, we further characterized these replication complexes (RCs) in Huh-7 cells that support active RNA replication of a subgenomic HCV replicon. Biochemical analysis showed that these membrane structures were resistant to Nonidet P-40 or Triton X-100 (TX-100) at 4 degrees C while solubilized by beta-octylglucoside at 4 degrees C or Triton TX-100 at 37 degrees C, characteristic of lipid rafts. Cholesterol sequestration assay further demonstrated the association between HCV nonstructural (NS) proteins and cholesterol-rich lipid rafts. The RCs contained both minus- and plus-strand HCV RNA, with the plus-stranded RNA being approximately 10-fold more abundant than the minus-strand. Furthermore, the HCV RNA and NS proteins were resistant to RNase and protease digestion, respectively, but became sensitive after treatment with the raft-disrupting agents. These results suggested that the HCV RCs are protected within lipid rafts. Detergent-resistant membrane (DRM) fractions containing NS proteins and viral RNA were capable of HCV RNA synthesis using the endogenous HCV RNA template. NS proteins were distributed in both the ER and the Golgi, but the majority of the active RCs were detected in the Golgi-derived membrane. Depletion of cellular cholesterol selectively reduced HCV RNA replication. These findings provide further insights into the mechanism of HCV replication in vivo.

Citing Articles

The triglyceride-synthesizing enzyme diacylglycerol acyltransferase 2 modulates the formation of the hepatitis C virus replication organelle.

Reichert I, Lee J, Weber L, Fuh M, Schlaeger L, Rossler S PLoS Pathog. 2024; 20(9):e1012509.

PMID: 39241103 PMC: 11410266. DOI: 10.1371/journal.ppat.1012509.


HCV-induced autophagy and innate immunity.

Lee J, Ou J Front Immunol. 2024; 15:1305157.

PMID: 38370419 PMC: 10874285. DOI: 10.3389/fimmu.2024.1305157.


Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.

Sami Alkafaas S, Abdallah A, Hassan M, Hussien A, Samy ElKafas S, Loutfy S BMC Public Health. 2024; 24(1):395.

PMID: 38321448 PMC: 10848368. DOI: 10.1186/s12889-024-17747-z.


The Implication of Sphingolipids in Viral Infections.

Thomas S, Samuel S, Hoch A, Syphurs C, Diray-Arce J Int J Mol Sci. 2023; 24(24).

PMID: 38139132 PMC: 10743733. DOI: 10.3390/ijms242417303.


Cell Entry of Avian Reovirus Modulated by Cell-Surface Annexin A2 and Adhesion G Protein-Coupled Receptor Latrophilin-2 Triggers Src and p38 MAPK Signaling Enhancing Caveolin-1- and Dynamin 2-Dependent Endocytosis.

Huang W, Wu Y, Liao T, Nielsen B, Liu H Microbiol Spectr. 2023; 11(3):e0000923.

PMID: 37097149 PMC: 10269738. DOI: 10.1128/spectrum.00009-23.